// App-Quantinova.ai

1787 : Efficacy and Safety of Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis

Researchers

Presenter

  • Robert B.M. Landew

Principal Investigators

  • Joachim Sieper

  • Philip J Mease

  • Robert D Inman

  • Xin Wang

  • Mei Li

  • Aileen L. Pangan

  • Jaclyn K. Anderson

Medical Centers

  • University of Amsterdam, Amsterdam, Netherlands

  • Brustzentrum Charite-Universitatsmedizin, Berlin, Germany

  • Swedish Medical Center and University of Washington School of Medicine, Seattle, WA

  • Department of Surgery, University of Toronto, Toronto, ON, Canada

  • AbbVie, Inc., North Chicago, IL

Locations

  • Netherlands

  • Germany

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • N/A

Biomarkers

  • C reactive protein

  • High sensitivity C-reactive protein

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Open Label

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved